bioAffinity Technologies, Inc. Warrant generated $6.2M in revenue in fiscal year 2025. This represents a decrease of 34.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $5.9M in revenue. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters bioAffinity Technologies, Inc. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BIAFW Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BIAFW Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More bioAffinity Technologies, Inc. Warrant financials
Frequently Asked Questions
What was bioAffinity Technologies, Inc. Warrant's revenue in fiscal year 2025?
bioAffinity Technologies, Inc. Warrant generated $6.2M in revenue in fiscal year 2025.
How fast is bioAffinity Technologies, Inc. Warrant's revenue growing?
bioAffinity Technologies, Inc. Warrant (BIAFW) revenue fell by 34.2% year over year, from $9.4M to $6.2M in fiscal year 2025.
What is bioAffinity Technologies, Inc. Warrant's revenue over the last twelve months?
bioAffinity Technologies, Inc. Warrant (BIAFW) reported $5.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was bioAffinity Technologies, Inc. Warrant's revenue in the most recent quarter?
bioAffinity Technologies, Inc. Warrant (BIAFW) reported $1.5M in revenue in Q2 2026. This represents an increase of 19.0% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what bioAffinity Technologies, Inc. Warrant (BIAFW) reported on that line in every period on record.